Sath Shukla - Insider Trading & Ownership

Entity
Individual
Location
C/O Ziopharm Oncology, Inc., One First Avenue, Parris Building #34, Boston, MA
Summary
The estimated net worth of Sath Shukla is at least $1.54M dollars as of August 29, 2024. Sath Shukla is the CEO & President of Spero Therapeutics, Inc. and owns shares of Spero Therapeutics, Inc. (SPRO) stock worth about $1.54M.
All Insider Reports
All Insider Reports

Ownership of Sath Shukla

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SPRO Spero Therapeutics, Inc. CEO & President $1.54M -$154K -9.1% Aug 27, 2024

Insider Transactions Reported by Sath Shukla:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.